Page 141 - 111111
P. 141

¥ÿ≈æ“À



              ‡§¬«‘π‘®©—¬«à“ Àπâ“∑’Ë¢Õß·æ∑¬å„π°“√·®âߢâÕ¡Ÿ≈μàÕºŸâªÉ«¬®”°—¥‡æ’¬ß·§à¢âÕ¡Ÿ≈∑’Ë·æ∑¬å‚¥¬

              ∑—Ë«‰ª (reasonable medical practitioner) ®–·®âß¿“¬„μâ ∂“π°“√≥凥’¬«°—πÀ√◊Õ§≈⓬§≈÷ß
                 (ÚÚ)                                                       (ÚÛ)
              °—π  ªí®®ÿ∫—π ÚÛ √—∞ ®“° ı √—∞¢Õß À√—∞Õ‡¡√‘°“„™â¡“μ√∞“ππ’È

                      Ú. Material risk À√◊Õ reasonable patient standard ¡“μ√∞“π¢Õß°“√

              ·®âߢâÕ¡Ÿ≈¡“μ√∞“ππ’È ‰¡à‰¥âπ”·π«∑“ß∑’˪ؑ∫—μ‘°—π„π∑“ß°“√·æ∑¬å (customary practice)

              ¡“æ‘®“√≥“ ·μàπ”§«“¡®”‡ªìπ∑’ËμâÕß°“√√Ÿâ¢âÕ¡Ÿ≈¢ÕߺŸâªÉ«¬¡“æ‘®“√≥“ ºŸâ‡¢’¬π¢Õ‡√’¬°
              ¡“μ√∞“ππ’È«à“ ç¡“μ√∞“π¢ÕߺŸâªÉ«¬∑’Ë¡’‡Àμÿº≈é À≈—ß®“°∑’Ë»“≈Æ’°“¢Õß√—∞·§π´— μ—¥ ‘π§¥’

              Natanson ¡“·≈â« ÒÚ ªï »“≈Õÿ∑∏√≥å√–¥—∫ Àæ—π∏√—∞ (Federal) ¢Õß D.C. circuit (the

              United States Court of Appeals for the District of Columbia Circuit) °≈—∫‡ÀÁπ«à“

              ‰¡à§«√ª≈àÕ¬„Àâ«ß°“√·æ∑¬åμ—¥ ‘π„®∑’Ë®–·®âßÀ√◊Õ‰¡à·®âߢâÕ¡Ÿ≈„¥·°àºŸâªÉ«¬ ´÷Ëß®–∑”„Àâ«ß°“√

              ·æ∑¬å≈–‡≈¬∑’Ë®–·®âߢâÕ¡Ÿ≈·°àºŸâªÉ«¬‰¥â ·æ∑¬å¡’Àπâ“∑’ËμâÕß·®âߢâÕ¡Ÿ≈§«“¡‡ ’ˬß∑—ÈßÀ¡¥∑’Ë
               ”§—≠ μàÕ§«“¡®”‡ªìπ¢ÕߺŸâªÉ«¬∑’ËμâÕß√Ÿâ¢âÕ¡Ÿ≈ §«“¡‡ ’ˬ߮–‰¥â™◊ËÕ«à“  ”§—≠ °ÁμàÕ‡¡◊ËÕ ç∫ÿ§§≈

              ´÷Ëß·æ∑¬å√ŸâÀ√◊Õ§«√®–√Ÿâ«à“À“°Õ¬Ÿà„π¿“«–‡¥’¬«°—π°—∫ºŸâªÉ«¬ ®–„Àâ§«“¡ ”§—≠μàÕ§«“¡‡ ’ˬßπ—Èπ
                                                               (ÚÙ)
              „πÕ—π∑’Ë®–μ—¥ ‘π„®‡¢â“√—∫°“√√—°…“À√◊ժؑ‡ ∏°“√√—°…“é  ·μ໓≈¬—߇°√ß«à“¡“μ√∞“π„À¡àπ’È
              ®–°àÕ¿“√–·≈–§«“¡√—∫º‘¥„Àâ·°à·æ∑¬å‡°‘π ¡§«√®“°§«“¡μâÕß°“√√Ÿâ¢âÕ¡Ÿ≈∑’Ë·ª≈°ª√–À≈“¥

              À√◊Õæ‘ ¥“√®“°ºŸâªÉ«¬∫“ß√“¬ »“≈®÷ß„™âºŸâªÉ«¬∑’Ë¡’‡Àμÿº≈À√◊Õ reasonable patient ‡ªìπ‡°≥±å

              ‰¡à„™à‡Õ“§«“¡μâÕß°“√√Ÿâ¢âÕ¡Ÿ≈¢ÕߺŸâªÉ«¬·μà≈–§π ´÷ËßÕ“®¡’∫“ß§π∑’Ë¡’§«“¡·ª≈°À√◊Õ

              æ‘ ¥“√¡“‡ªìπ‡°≥±å


                      Û. Subjective patient-based standard À√◊Õ¡“μ√∞“π¢Õßªí®‡®°ºŸâªÉ«¬

              ¡“μ√∞“ππ’Ȱ”Àπ¥Àπâ“∑’Ë∑’Ë·æ∑¬å®–μâÕß·®âߢâÕ¡Ÿ≈·°àºŸâªÉ«¬ μ“¡§«“¡μâÕß°“√„π°“√
              μ—¥ ‘π„®¢ÕߺŸâªÉ«¬·μà≈–§π ·¡â«à“§«“¡μâÕß°“√π—Èπ ºŸâªÉ«¬‚¥¬∑—Ë«‰ª∑’˰ժ√¥â«¬‡Àμÿº≈‰¡à‰¥â

              Õ¬“°√ŸâÀ√◊Õ‡ÀÁπ«à“‡ªìπ¢âÕ¡Ÿ≈∑’ˉ¡à®”‡ªìπ ¡“μ√∞“ππ’È∂◊Õ«à“‡ªìπ¡“μ√∞“π∑’Ë„Àâ§«“¡§ÿâ¡§√Õß



              (ÚÚ)
                 Natanson v. Kline, 350 P.2d 1093, 1106 (Kan. 1960).
              (ÚÛ)
                 David M. Studdert et al., Geographic Variation in Informed Consent Law: Two Standards
                 for Disclosure of Treatment Risks, 4 J. EMPIRICAL LEGAL STUD. 103, 105 (2007).
              (ÚÙ)
                 Canterbury v. Spence, 464 F.Úd 787 (D.C. Cir. 1972).



              130
              130
              130                                                             ‡≈à¡∑’Ë Ú  ªï∑’Ë ˆˆ
              130
              130
   136   137   138   139   140   141   142   143   144   145   146